
An estimated two million people in the UK are living with undiagnosed chronic obstructive pulmonary disease

Over 240 million people worldwide live with chronic hepatitis B

The new three-year agreement builds on an existing two-year relationship

COPD affects nearly 400 million people globally and is the third leading cause of death worldwide

PH has a five‑year survival rate of only around 50% and affects up to 82 million people worldwide

Around 1.4 million people in the UK are diagnosed with COPD, with two million thought to be undiagnosed

RSV affects approximately 64 million people around the world each year

Symptoms of COPD include breathlessness, persistent cough and frequent chest infections

Approval supported by positive results from phase 3 trial

The deal includes a PDE3/4 inhibitor in clinical development for COPD

More than 50,000 cases of the blood cancer are diagnosed in Europe each year

The deal includes a drug approved in the US for chronic obstructive pulmonary disease